Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 6, 2004, Pages 641-649

  Peng, Shiyong ^a   Wuu, Joanne ^b   Mufson, Elliott J ^b   Fahnestock, Margaret ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Cholinergic; Nerve growth factor (NGF); Neurodegeneration; Neurotrophic factor; Parietal cortex; Western blotting

Indexed keywords

BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN PRECURSOR;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL SURVIVAL; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOREBRAIN; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; PARIETAL LOBE; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 2942536284     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.6.641     Document Type: Article

References (72)

1. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983;219:1184-90
2. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978;2:1457-59
3. Gilmor ML, Erickson JD, Varoqui H, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 1999;411:693-704
4. Davies P. Challenging the cholinergic hypothesis in Alzheimer disease. JAMA 1999;281:1433-34
5. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-55
6. Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: Correlation with Alzheimer's neuropathology. J Alzheimers Dis 2003;5:39-48
7. Martinez HJ, Dreyfus CF, Jonakait GM, Black IB. Nerve growth factor selectively increases cholinergic markers but not neuropeptides in rat basal forebrain in culture. Brain Res 1987;412:295-301
8. Gage FH, Armstrong DM, Williams LR, Varon S. Morphological response of axotomized septal neurons to nerve growth factor. J Comp Neurol 1988;269:147-55
9. Rylett RJ, Williams LR. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci 1994;17:486-90
10. Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons. J Neurochem 2001;77:253-62
11. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 1985;4:1389-93
12. Seiler M, Schwab ME. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 1984;300:33-39
13. Ferguson IA, Schweitzer JB, Bartlett PF, Johnson EM Jr. Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J Comp Neurol 1991;313:680-92
14. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 1999;57:451-84
15. Nitta A, Murase K, Furukawa Y, Hayashi K, Hasegawa T, Nabeshima T. Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats. Neuroscience 1993;57:495-99
16. Chen KS, Nishimura MC, Armanini MP, Crowley C, Spencer SD, Phillips HS. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. J Neurosci 1997;17:7288-96
17. Appel SH. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol 1981;10:499-505
18. Jette N, Cole MS, Fahnestock M. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Mol Brain Res 1994;25:242-50
19. Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV. Nerve growth factor receptor mRNA distribution in human brain: Normal levels in basal forebrain in Alzheimer's disease. Mol Brain Res 1989;5:1-7
20. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J, Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease. J Neurosci 1993;13:2540-50
21. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 1996;7:2925-28
22. Fahnestock M, Scott SA, Jette N, Weingartner JA, Crutcher KA. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Mol Brain Res 1996;42:175-78
23. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000;57:846-51
24. Mufson EJ, Ikonomovic MD, Styren SD, et al. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer's disease. Arch Neurol 2003;60:1143-48
25. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001;18:210-20
26. Mufson EJ, Li JM, Sobreviela T, Kordower JH. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport 1996;8:25-29
27. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 1997;146:91-103
28. Mufson EJ, Ma SY, Cochran EJ, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 2000;427:19-30
29. Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2001;437:296-307
30. Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res 2002;27:1035-48
31. Hock C, Heese K, Muller-Spahn F, Hulette C, Rosenberg C, Otten U. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 1998;241:151-54
32. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995;15:6213-21
33. Mufson EJ, Conner JM, Kordower JH. Nerve growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis. Neuroreport 1995;6:1063-66
34. Mitchell TW, Mufson EJ, Schneider JA, et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 2002;51:182-89
35. Cooper JD, Salehi A, Delcroix JD, et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 2001;10439-44
36. Mufson EJ, Ma SY, Dills J, et al. Loss of basal forebrain p75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2002;443:136-53
37. Kordower JH, Chu Y, Stebbins GT, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001;49:202-13
38. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-44
40. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
41. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59
42. National Institute on Aging and Reagan Institute working group on diagnosis criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of AD. Neurobiol Aging 1997;18:S1-S3
43. Van der Zee CE, Rashid K, Le K, et al. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 1995;15:5316-23
44. Mobley WC, Schenker A, Shooter EM. Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 1976;15:5543-52
45. Petrides PE, Shooter EM. Rapid isolation of the 7S-nerve growth factor complex and its subunits from murine submaxillary glands and saliva. J Neurochem 1986;46:721-25
46. Wilson RS, Schneider JA, Barnes LL, et al. Effect of apolipoprotein E ε4 allele status on decline in different cognitive systems and development of Alzheimer's disease over a 6-year period. Arch Neurol 2002;59:1154-60
47. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E 2 allele and decline in episodic memory. J Neurol Neurosurg Psych 2002;73:672-77
48. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-53
49. Reinshagen M, Geerling I, Eysselein VE, et al. Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone. J Neurochem 2000;74:2127-33
50. Chen Y, Dicou E, Djakiew D. Characterization of nerve growth factor precursor protein expression in rat round spermatids and the trophic effects of nerve growth factor in the maintenance of Sertoli cell viability. Mol Cell Endocrinol 1997;127:129-36
51. Seidah NG, Benjannet S, Pareek S, et al. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J 1996;314:951-60
52. Takeda M, Nishimura T, Hariguchi S, et al. Study of cytoskeletal proteins in fibroblasts cultured from familial Alzheimer's disease. Acta Neurol Scand 1991;84:416-20
53. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: Decreased levels in Alzheimer's disease. Mol Brain Res 2000;76:347-54
54. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30
55. Poirier J, Minnich A, Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann Med 1995;27:663-70
56. Soininen H, Lehtovirta M, Helisalmi S, Linnaranta K, Heinonen O, Riekkinen P Sr. Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele. Neuroreport 1995;6:2518-20
57. Allen SJ, MacGowan SH, Tyler S, et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 1997;239:33-36
58. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982;215:1237-39
59. Fahnestock M, Yu G, Michalski B, et al. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature NGF. J Neurochem (in press)
60. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-4500
61. Crutcher KA, Collins F. Entorhinal lesions result in increased nerve growth factor-like growth-promoting activity in medium conditioned by hippocampal slices. Brain Res 1986;399:383-89
62. Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985;230:1179-81
63. Cotman CW, Matthews DA, Taylor D, Lynch G. Synaptic rearrangement in the dentate gyrus: Histochemical evidence of adjustments after lesions in immature and adult rats. Proc Natl Acad Sci USA 1973;70:3473-77
64. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217-81
65. Zhou J, Valletta JS, Grimes ML, Mobley WC. Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor. J Neurochem 1995;65:1146-56
66. Saboori AM, Young M. Nerve growth factor: Biosynthetic products of the mouse salivary glands. Characterization of stable high molecular weight and 32,000-dalton nerve growth factors. Biochemistry 1986;25:5565-71
67. Edwards RH, Selby MJ, Garcia PD, Rutter WJ. Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. J Biol Chem 1988;263:6810-15
68. Lakshmanan J, Beattie GM, Hayek A, Burns C, Fisher DA. Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique. Neurosci Lett 1989;99:263-67
69. Fahnestock M, Yu G, Coughlin MD. ProNGF: A neurotrophic or an apoptotic molecule? Progr Brain Res 2003;146:101-10
70. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001;294:1945-48
71. Miller FD, Kaplan DR. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 2001;58:1045-53
72. Chao MV, Bothwell M. Neurotrophins: To cleave or not to cleave. Neuron 2002;33:9-12